Stockreport

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF Event to be webcast live on Thursday, December 12 at 4:30 p.m. ET CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) ( [Read more]